Amgen

The Zacks Analyst Blog Highlights: Netflix, Exxon Mobil, Amgen, Humana And Fedex

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exxon Mobil Corporation (XOM): Free Stock Analysis Report Humana Inc. (HUM): Free...
Related topics: Netflix (NFLX), Exxon Mobil Corporation, Fedex

Read More →

Amgen (amgn) Looks Good: Stock Adds 8.2% In Session

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amgen Inc. (AMGN): Free Stock Analysis Report Emergent Biosolutions Inc. (EBS): Free...

Read More →

Amgen Gets Favorable Appeals Court Ruling For Enbrel Patent

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report Pfizer Inc. (PFE):...
Related topics: Patents, Pfizer

Read More →

Why Amgen Shares Jumped Today

Shares of Amgen (NASDAQ: AMGN) were jumping 8.4% higher as of 3:09 p.m. EDT on Wednesday. The nice gain came after a U.S. appeals court ruled in Amgen's favor in a case challenging the validity of two patents for immunology drug Enbrel.In 2019, the...
Related topics: Nasdaq, US Equity Markets, Patents

Read More →

Signs That Your Trading Will Ruin Your Retirement - June 30, 2020

This report will help you steer clear of the most common mistakes, like trying to time the market, lack of diversification in your portfolio, and many more. Get Your FREE Guide Now Amgen Inc. (AMGN): Free Stock Analysis Report Bristol...

Read More →

Better Buy: Amgen Vs. Bristol Myers Squibb

Amgen (NASDAQ: AMGN) owes a debt of thanks to Bristol Myers Squibb (NYSE: BMY). For BMS to completed its acquisition of Celgene last year, regulators required that Celgene first sell immunology drug Otezla. Amgen was more than happy to shell out...
Related topics: Bristol-Myers Squibb, Nasdaq, US Equity Markets, Shell

Read More →

Abbvie's (abbv) Sbla For Botox Gets Acceptance From Fda

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Amgen Inc. (AMGN): Free Stock...

Read More →

The Zacks Analyst Blog Highlights: Facebook, Adobe, Amgen, Lowe's And Tjx

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The TJX Companies, Inc. (TJX): Free Stock Analysis Report Lowes Companies, Inc....
Related topics: Facebook, Social Media

Read More →

Top Stock Reports For Facebook, Adobe & Amgen

Monday, June 22, 2020The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Adobe Systems (ADBE) and Amgen (AMGN)....
Related topics: Facebook, Social Media

Read More →

Signs That Your Trading Will Ruin Your Retirement - June 04, 2020

Maybe you're a seasoned investor and have a good track record with stock-picking. And you may have a robust retirement portfolio - perhaps including some Zacks Top Retirement stock selections such as:Amgen (AMGN), AbbVie (ABBV) and Bristol-Myers...
Related topics: Bristol-Myers Squibb

Read More →

Why Is Amgen (amgn) Down 4% Since Last Earnings Report?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amgen Inc. (AMGN): Free Stock Analysis Report To read this article on Zacks.com click...

Read More →

The Extreme Risks Of Trading Your Own Retirement Assets - May 18, 2020

This report will help you steer clear of the most common mistakes, like trying to time the market, lack of diversification in your portfolio, and many more. Get Your FREE Guide Now AbbVie Inc. (ABBV): Free Stock Analysis Report Amgen Inc....

Read More →

Is Now Still A Good Time To Buy Amgen?

Amgen (NASDAQ: AMGN) investors who were patient in February when the company's year-end numbers were down slightly were rewarded late last month when the Thousand Oaks, Calif., biotech giant's first-quarter 2020 results came out.Revenue and...
Related topics: Nasdaq, US Equity Markets

Read More →

The Zacks Analyst Blog Highlights: Amgen, Bhp, Altria, Apple And Target

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Target Corporation (TGT): Free Stock Analysis Report Altria Group Inc (MO): Free...
Related topics: Altria Group (MO), Apple (AAPL)

Read More →

Why Amgen Soared In April

Shares of the biotech heavyweight Amgen (NASDAQ: AMGN) gained an astounding 20.9% during the month of April, according to data from S&P Global Market Intelligence. Amgen's stock took flight in April for two underlying reasons. First, Amgen's...
Related topics: Nasdaq, US Equity Markets

Read More →

Radius' (rdus) Q1 Earnings Miss Estimates, Sales Surpass

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Amgen Inc (AMGN): Free Stock...

Read More →

The Zacks Analyst Blog Highlights: Amazon, Apple, Gilead Sciences, Amgen And Visa

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amazon.com, Inc. (AMZN): Free Stock Analysis Report Apple Inc. (AAPL): Free Stock...
Related topics: Amazon, Amazon (AMZN), Apple (AAPL)

Read More →

Amgen Inc (amgn) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool.Amgen Inc (NASDAQ: AMGN)Q1 2020 Earnings CallApr 30, 2020, 5:30 p.m. ETOperatorContinue reading
Related topics: Nasdaq, US Equity Markets

Read More →

The Extreme Risks Of Trading Your Own Retirement Assets - April 30, 2020

This report will help you steer clear of the most common mistakes, like trying to time the market, lack of diversification in your portfolio, and many more. Get Your FREE Guide Now AbbVie Inc. (ABBV): Free Stock Analysis Report Amgen Inc....

Read More →

Better Buy: Amgen Vs. Johnson & Johnson

If you're the kind of investor who likes to go big or go home, Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ) might be right up your alley. Amgen ranks as the biggest biotech in terms of market cap. Johnson & Johnson is the biggest...
Related topics: Nasdaq, US Equity Markets

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.